Jacobsson S O
Acta Vet Scand. 1966;7(4):303-20. doi: 10.1186/BF03547120.
A total of 34 sheep of both sexes were used in the experiments. Se-selenomethionine in a tracer dose and Se-sodium selenite at three dose-levels (from a tracer dose to a therapeutic dose) were injected by the subcutaneous route. Se-selenocystine in a dose that may be regarded as higher than a therapeutic dose of selenium was given intravenously. Se-sodium selenite in a tracer dose and a therapeutic dose was injected intraruminally. High levels of Se were noted mainly in renal cortex, liver, and adrenal cortex after injection of Se-sodium selenite, whereas the values for skeletal muscle were low. Injections of Se-selenomethionine and Se-selenocystine resulted in higher Se-levels in pancreas than did tracer doses of Se-sodium selenite. The tissues retained a greater percentage of a tracer dose than of a therapeutic dose of Se-labelled sodium selenite, with the exception of the liver, in which the percentage retention was relatively constant, irrespective of the dose level. The amount of Se recovered in the tissues was higher after subcutaneous than after intraruminal injection of a small selenium dose. The Se-levels differed very little or not at all when a therapeutic dose was injected by these two routes. These results suggest that in sheep the storage of inorganic selenium is limited. In most tissues the difference between the Se-concentration at 2 days and that at 13 days was small after subcutaneous injection of a therapeutic dose of selenium. The Se-content in renal cortex, muscle, and lung was higher, however, at 2–8 days than at 13–22 days. It was also higher in the rumen wall at 2 days than later. When Se-sodium selenite was injected subcutaneously, most of the radioactivity in the tissues was present in the protein precipitated with trichloracetic acid, the recoveries in the precipitate being 71–83 per cent at 2 days and 78–94 per cent at 13 days. The proportion of plasma-Se bound with the proteins averaged 53 per cent at 1 hour and 90 per cent at 7 days.
实验共使用了34只雌雄绵羊。以示踪剂量的硒代蛋氨酸和三个剂量水平(从示踪剂量到治疗剂量)的亚硒酸钠通过皮下途径注射。以静脉注射的方式给予了剂量可视为高于硒治疗剂量的硒代胱氨酸。以示踪剂量和治疗剂量的亚硒酸钠进行瘤胃内注射。注射亚硒酸钠后,高浓度的硒主要存在于肾皮质、肝脏和肾上腺皮质中,而骨骼肌中的硒含量较低。注射硒代蛋氨酸和硒代胱氨酸后,胰腺中的硒水平高于示踪剂量的亚硒酸钠。除肝脏外,各组织对示踪剂量的硒的保留百分比高于治疗剂量的硒标记亚硒酸钠,肝脏中的保留百分比相对恒定,与剂量水平无关。皮下注射小剂量硒后,组织中回收的硒量高于瘤胃内注射。当通过这两种途径注射治疗剂量时,硒水平差异很小或几乎没有差异。这些结果表明,绵羊体内无机硒的储存是有限的。皮下注射治疗剂量的硒后,大多数组织在2天和13天时的硒浓度差异很小。然而,肾皮质、肌肉和肺中的硒含量在2 - 8天高于13 - 22天。瘤胃壁在2天时的硒含量也高于之后。当皮下注射亚硒酸钠时,组织中的大部分放射性存在于用三氯乙酸沉淀的蛋白质中,沉淀中的回收率在2天时为71 - 83%,在13天时为78 - 94%。与蛋白质结合的血浆硒比例在1小时时平均为53%,在7天时为90%。